Press Release BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) 8 hours ago
Press Release BridgeBio to Report Second Quarter 2026 Financial Results and Commercial Updates on August 10, 2026 at 4:30 pm ET Aug 3